Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cell Damage”

171 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 171 results

Not applicableStudy completedNCT04368052
What this trial is testing

Liver Transplant Does it Affect the Brain

Who this might be right for
Brain DamagePostoperative Cognitive DysfunctionNeuron Specific Enolase+1 more
Ege University 33
Not applicableStudy completedNCT05529485
What this trial is testing

Quantification of Factors Influencing Endothelial Damage During Phacoemulsification

Who this might be right for
Endothelial Cell Loss, CornealCataractPhacoemulsification
Centre Hospitalier Régional Metz-Thionville 121
Testing effectiveness (Phase 2)Study completedNCT03207347
What this trial is testing

A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

Who this might be right for
MesotheliomaUveal MelanomaRenal Cell Carcinoma+1 more
University of Florida 37
Testing effectiveness (Phase 2)UnknownNCT03944447
What this trial is testing

Outcomes Mandate National Integration With Cannabis as Medicine

Who this might be right for
Chronic PainChronic Pain SyndromeChronic Pain Due to Injury+30 more
OMNI Medical Services, LLC 200,000
Not applicableLooking for participantsNCT05213572
What this trial is testing

Observational Study to Deeply Phenotype Major Organs in Sickle Cell Disease After Curative Therapies

Who this might be right for
Mortality in Sickle CellSickle Cell Cardiopulmonary ComplicationsSickle Cell Organ Damage+2 more
National Heart, Lung, and Blood Institute (NHLBI) 200
Not applicableStudy completedNCT00070889
What this trial is testing

Brain Cell Injury in Patients With A First Episode of Psychosis

Who this might be right for
Psychoses
National Center for Complementary and Integrative Health (NCCIH) 30
Testing effectiveness (Phase 2)Study completedNCT04063215
What this trial is testing

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Who this might be right for
Traumatic Brain Injury
Hope Biosciences LLC 24
Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Large-scale testing (Phase 3)Looking for participantsNCT06585410
What this trial is testing

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals 369
Not applicableUnknownNCT03106246
What this trial is testing

Circulating Extracellular Vesicles Released by Human Islets of Langerhans

Who this might be right for
Type1 Diabetes MellitusType2 DiabetesIslet Cell Transplantation
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Early research (Phase 1)Ended earlyNCT01557543
What this trial is testing

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Who this might be right for
Heart DiseaseIschemic Heart DiseaseCoronary Artery Disease+1 more
National Heart, Lung, and Blood Institute (NHLBI) 24
Not applicableUnknownNCT05731375
What this trial is testing

Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage

Who this might be right for
Doxorubicin Induced CardiomyopathyChemotherapeutic ToxicityB-cell Lymphoma+1 more
UMC Utrecht 12
Not applicableActive Not RecruitingNCT06620666
What this trial is testing

NEUROmuscular Training for Enhanced AGE Longevity

Who this might be right for
AgingPhysical ActivityTraining
University of Valencia 390
Not applicableLooking for participantsNCT06096272
What this trial is testing

Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy

Who this might be right for
Cerebral PalsyMobile Phone UsePediatric ALL+2 more
Children's Hospital Los Angeles 30
Early research (Phase 1)Study completedNCT03022409
What this trial is testing

Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC).

Who this might be right for
Head and Neck Squamous Cell Carcinoma
AstraZeneca 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03263650
What this trial is testing

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Who this might be right for
Prostate Cancer AggressivenessProstate Carcinoma
M.D. Anderson Cancer Center 96
Not applicableLooking for participantsNCT06781970
What this trial is testing

Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts

Who this might be right for
Endothelial Cell Loss, CornealCataract and Intraocular Lens (IOL) Surgery
Indonesia University 120
Testing effectiveness (Phase 2)UnknownNCT05199766
What this trial is testing

Hemolysis Related Complications in SCD. A Phase II Study With Voxelotor

Who this might be right for
Sickle Cell Disease
Assistance Publique - Hôpitaux de Paris 30
Not applicableUnknownNCT03652142
What this trial is testing

Predictive Biomarkers for Response to Nivolumab in Head and Neck Squamous Cell Carcinoma

Who this might be right for
HNSCCDNA DamageDNA Double Strand Break
Attikon Hospital 50
Post-approval studies (Phase 4)Study completedNCT00868088
What this trial is testing

Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip

Who this might be right for
Actinic CheilitisSquamous Cell Carcinoma In-situ (SCC-is)Squamous Cell Carcinoma (SCC)+2 more
Tufts Medical Center 34
Load More Results